Viewing Study NCT05565794


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-27 @ 11:20 PM
Study NCT ID: NCT05565794
Status: TERMINATED
Last Update Posted: 2025-04-13
First Post: 2022-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module